Investors rush into biotechs working on coronavirus vaccine
A nurse holds up a one dose bottle and a prepared syringe of measles, mumps and rubella virus vaccine made by Merck at the Utah County Health Department on April 29, 2019 in Provo, Utah.
George Frey | Getty Images
The deadly coronavirus worsened quickly this month, roiling the financial markets as investors fled risk assets amid concerns the outbreak would disrupt the global economy.…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.